Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
|
|
Astex Pharmaceuticals, Inc (ASTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/20/2011 |
8-K
| Appointed a new director|
Docs:
|
"SuperGen Completes Acquisition of Astex Therapeutics DUBLIN, Calif., July 20, 2011 — SuperGen, Inc. , a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced it has closed the transaction to acquire Astex Therapeutics Limited , a privately held, UK-based biotechnology company developing targeted therapies. Today, Astex Therapeutics Limited became a wholly owned subsidiary of SuperGen, Inc. SuperGen purchased all outstanding shares of Astex for approximately $25 million in cash and 32.4 million shares of SuperGen common stock representing 35 percent of the total post closing shares outstanding. In addition, SuperGen will pay deferred consideration in the amount of $30 million in either stock or cash, at the discretion of the combined entity, ...",
"Employment Agreement between Astex Technology Limited and Harren Jhoti (Astex Technology Limited changed its name to Astex Therapeutics Limited on June 27, 2005)",
"Employment Agreement between Astex Technology Limited and Martin Buckland (Astex Technology Limited changed its name to Astex Therapeutics Limited on June 27, 2005)" |
|
|
|